🇺🇸 FDA
Patent

US 12263143

Ionic channel modulation as a method for treating tumors through inflammasome activation

granted A61KA61K31/138A61K31/166

Quick answer

US patent 12263143 (Ionic channel modulation as a method for treating tumors through inflammasome activation) held by INSTITUT PASTEUR DE MONTEVIDEO expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
INSTITUT PASTEUR DE MONTEVIDEO
Grant date
Tue Apr 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/138, A61K31/166, A61K31/167, A61K31/4166